Adherium Ltd. (AU:ADR) has released an update.
Adherium Limited reported a decrease in revenue by 73.7% and a slight increase in losses compared to the previous year. The company is focused on expanding its remote patient monitoring services in the U.S. healthcare market, aiming for cash flow positivity. Their new strategy involves partnering with U.S. health entities, enhancing patient adherence and proper inhaler use through remote monitoring to improve the quality of life for asthma sufferers.
For further insights into AU:ADR stock, check out TipRanks’ Stock Analysis page.